Can You Get 5 Doses Out of a Wegovy Pen — and Should You Try?

The four-dose limit is not a commercial choice, it is a clinical one

The decision you are facing is straightforward, even if the temptation is understandable: pens are expensive and a "wasted" dose feels frustrating. But the four-dose structure of the Wegovy pen is a deliberate feature of its design, not a conservative estimate of how much semaglutide is loaded.

Each pen delivers a metered, fixed volume per injection. Novo Nordisk engineers the device so that four injections can be completed reliably, with consistent accuracy. How a Wegovy pen's doses are counted comes down to the mechanics of a pre-set plunger mechanism, not a reservoir you can drain further.

There is a small manufacturing overfill inside the cartridge, this is standard across injectable medicines and exists to ensure the fourth dose reaches full volume, not to fund an unofficial fifth. That residual fluid is inaccessible under normal use and is not a safe or sanctioned source of medication. The NHS semaglutide patient information is clear that doses should be taken exactly as directed by your prescriber, using the pen as instructed in the leaflet.

The pen itself will also signal that it is finished: the dose counter reaches zero and the button typically locks. If you are wondering whether a golden dose can be retrieved from a finished Wegovy pen, forcing a pen past this point does not release medication reliably, it risks an air injection, a partial dose, or nothing at all.

What actually happens if you try for a fifth dose

You may have seen this discussed in online forums, and if you are reading this now, you are probably trying to work out whether the advice there is reliable. It mostly is not.

The residual volume left after four doses is not standardised across pens or batches. Attempts to recover it (rotating the pen, priming again, pushing past the lock) may produce a fraction of the nominal dose, zero, or a volume you cannot measure. Semaglutide is dosed precisely because its titration schedule matters: an undermeasured injection is not a minor inconvenience, it disrupts the concentration-response relationship your prescriber built into your plan.

There is also a contamination risk. Needles should be replaced before every injection; a needle left on between attempts, or a pen handled outside its storage guidelines, raises infection risk at the injection site. The Wegovy dosing schedule overview covers why each step in the titration exists, consistency across those steps is the point.

In short: if you are considering taking two doses of Wegovy to compensate, or stretching a pen beyond its design, neither is a clinical option. Both are workarounds that create meaningful risk for a marginal and unmeasurable gain.

When something goes wrong with your pen before four doses are done

A different scenario is worth separating out: a pen that seems to malfunction mid-course, delivering fewer than four reliable doses before the mechanism fails. This happens occasionally and is not the same as trying to extend a finished pen.

If a pen malfunctions, do not try to repair or override it. Contact your prescriber or the dispensing pharmacy. Novo Nordisk has a product support line and most regulated UK pharmacies (including GPhC-registered online pharmacies) have aftercare pathways to handle exactly this situation. Missing a dose because of a faulty device is not the same as deliberately skipping one; your prescriber can advise on whether to resume at the next scheduled injection or adjust the timing.

The broader principle: any uncertainty about your pen (doses, storage, timing, what to do after a missed injection) belongs with your clinical team, not with a forum thread. The Wegovy SmPC on the eMC is the authoritative source for device instructions, and your prescriber interprets it for your individual circumstances.

Planning your supply so the question never arises

The cleanest answer to the five-dose question is not to need it. That means ordering your next pen before the current one is finished, understanding exactly when each dose falls due, and keeping a note of your injection day so supply gaps do not catch you out.

Cost is often the real pressure behind the question. Wegovy is a private prescription medicine and the per-pen price has risen since mid-2025. If cost is making you consider stretching a pen, it is worth reading about where to source Wegovy in the UK through a regulated pharmacy, and understanding what a legitimate price actually includes.

It is also worth knowing that the highest licensed Wegovy dose is now 7.2mg, a pen format approved by the MHRA in April 2026. Whether a particular dose or format is right for your stage of treatment is a clinical decision, not one to make by rationing a pen you already have.

If your current plan feels unsustainable, the right move is a conversation with your prescriber. At nume, that conversation can happen through a clinical review, speak to our prescribers about whether your current treatment plan is working as it should.